Form 4: Belite Bio CEO Sells Shares
Insider Transaction (Form 4)
Yu-Hsin Lin, Chief Executive Officer and a Director of Belite Bio, Inc, sold 365 shares of common stock on August 12, 2026.
Summary
- Open-market sale: disposed of 142 American depositary share at $180.00 ($25,560) on August 12, 2026; holds 170,792 after (Direct).
- Open-market sale: disposed of 223 American depositary share at $180.57 ($40,267) on August 12, 2026; holds 170,569 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $65,827 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Yu-Hsin Lin — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Open-market sale | American depositary share | 142 | $180 | $25.6K | 170,792 |
| 2026-08-12 | Open-market sale | American depositary share | 223 | $181 | $40.3K | 170,569 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Open-market sale (142 shares) |
| 2026-08-12 | Open-market sale (223 shares) |
Keywords
insider transaction, Form 4, BLTE, BELITE BIO, INC, bearish, Yu-Hsin Lin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.